返回
Novelstem International Corp（NSTM）价格
NSTM 股价走势图
NSTM 收益
Novelstem International Corp
$0.01
75%
$0
收盘价：Jan 20, 16:00:00 GMT-5
$0.01
0%
$0
盘后：Jan 20, 20:00:00 GMT-5
关键数据
前收盘价
$0.01
开盘价
$0.0175
当日区间
$0.0175 - $0.0175
52周范围
$0.01 - $0.04
交易量
16.0K
平均成交量
28.1K
每股收益（TTM）
-0.00
股息收益率
--
市值
$820.4K
什么是 NSTM？
NovelStem International Corp. develops novel diagnostic technology that can predict patients resistance to chemotherapy allowing for cancer treatments and the potential to reduce resistance to chemotherapy. The company is headquartered in Boca Raton, Florida. The firm's primary assets are NewStem Ltd (NewStem) and NetCo Partners (NetCo). NewStem focuses on the development and commercialization of diagnostic technology that can predict patients’ anti-cancer drug resistance, allowing for targeted cancer treatments and the potential to reduce resistance to chemotherapy. NewStem is principally focused on utilizing proprietary human Pluripotent Stem Cells (hPSCs) and Haploid human Pluripotent Stem Cells (HhPSCs) in the development of diagnostic and therapeutic products in oncology. Its NewStem Software Diagnostic Device (NSDD) is a bioinformatics-based software medical device platform that provides oncologists with information regarding the presence of mutations in tumors, which may confer patient resistance to certain anti-cancer drugs. NetCo is a media business interest which owns Net Force, a book publishing franchise.